Paradeep Phosphates share price today

Paradeep Phosphates Ltd's share price was ₹137.21 at the close on 4 November 2026. It has been rising for 12 weeks. That is 4.1% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹105 and ₹174, and at that close it sat 46% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Paradeep Phosphates Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 2 weeks running.

Over the last 4.4 years the share price moved +213% while the NIFTY 500 moved +55%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 23 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

1. Foreign funds (FIIs) cut their stake for 4 quarters in a row

   From 15% to 4.8% of the company by the September 2026 quarter.

3. Indian funds and insurers (DIIs) raised their stake for 3 quarters in a row

   From 13.3% to 20.3% of the company by the September 2026 quarter.

For July to September 2026 (the quarter ended 30 September 2026), Paradeep Phosphates reported revenue of ₹7,364 crore, up 7.2% from ₹6,872 crore a year earlier, and a profit of ₹121 crore, down 64.6% from ₹342 crore.

Paradeep Phosphates results: July to September 2026 against a year earlier

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

The newest call in our records is from 31 July 2026, about April to June 2026; a call about these results is not in our records yet.

From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.

Paradeep Phosphates closed at ₹137.21 on 4 November 2026, down 21.1% from ₹173.95 a year earlier (7 November 2025) and up 114.2% over three years. Its highest weekly close since May 2022 was ₹224.77 on 8 August 2025.

Paradeep Phosphates share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

236 weekly closes from 27 May 2022 to 4 November 2026.

4 Nov 2026: Paradeep Phosphates closed at ₹137.21, up 6.3% on the week and down 9.3% on the month. Results for July to September 2026: Revenue up 7.2% and profit down 64.6% on a year earlier.

Earlier

• 4 Sep 2026: ex-date for a dividend of ₹1.50 a share.
• 31 Jul 2026: Paradeep Phosphates held its results call for April to June 2026. Management guided: FY27 company-level operating profit per ton expected at ₹5,000-5,500, with ₹5,000 planned by year-end; backward integration is expected to lift sustainable operating profit per ton by 30.0-35.0%, toward ₹7,000-plus in 2-2.5 years.

Paradeep Phosphates paid ₹1.50 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 1.09% at the ₹137.21 close on 4 November 2026. The last was a dividend of ₹1.50 a share, ex-date 4 September 2026.

Paradeep Phosphates dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date.

Yes. Paradeep Phosphates Ltd paid out 16% of its profit as dividends in FY26, and it paid a dividend in 5 of its last 8 reported years.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 31 July 2026, Paradeep Phosphates' management guided: FY27 company-level operating profit per ton expected at ₹5,000-5,500, with ₹5,000 planned by year-end; backward integration is expected to lift sustainable operating profit per ton by 30.0-35.0%, toward ₹7,000-plus in 2-2.5 years.

“We will continue producing at the plant, but we would not like to produce if raw material prices are too steep or if there are supply chain disruptions because of the war; any such shortfall in production will be made good through trading.”Rajiv Nambiar, on the call for April to June 2026

What management guided

• Phosphoric acid capacity to move from 5 lakh to 6 lakh tons by December and from 6 lakh to 7 lakh tons by August-September next year; granulation capacity to move from 3.7 to 4 by December, with the unit not restated.
• The larger one-phase expansion adds 3 lakh tons each of phosphoric acid and sulfuric acid, with completion planned around Q2 of 2029-30; final commercial discussions are under way.
• Aluminum fluoride project: ₹250 crore of spending, 15,000 tons per annum capacity, approximately ₹180-200 crores top line and at least ₹60 crore operating profit; commissioning expected in 22-24 months, versus 20-24 months in the initial answer.
• Almost half a million tons of DAP, NPK, TSP and ammonium sulfate imports have been secured for Rabi, supporting Q2 and Q3 through December.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 31 July 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.

When Paradeep Phosphates reports October to December 2026, these are the 4 checks that show whether the story is still on course. First: Phosphoric acid capacity should reach 6 lakh tons by December, with the next 1 lakh tons planned by August-September next year; granulation debottlenecking from 3.7 to 4 is also due by December.

Paradeep Phosphates is on one of our India lists: Small & mid cap stocks.

Paradeep Phosphates Ltd earned ₹121 Cr of net profit in the Sep 2026 quarter, −64.6% on the same quarter a year earlier. Full-year FY26 profit was ₹996 Cr. Over 7 years profit has grown 30.0% a year on average. That is 1.6% of the quarter's revenue. The same quarter a year earlier earned ₹342 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹996 Cr (+50.5% on the year before).

Why profit moved: revenue changed +7.2% on a year earlier and the margin moved −4.0 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed −15.7% and revenue +17.6%. Profit is growing slower than sales: rising costs are taking part of the growth.

Paradeep Phosphates Ltd reported ₹7,364 Cr of revenue in the Sep 2026 quarter, +7.2% on the same quarter a year earlier. That is the 9th quarter in a row with growth on the year before. Over 7 years it has grown 25.9% a year on average. The last full year, FY26, came in at ₹21,826 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹23,939 Cr.

FY26 revenue was ₹21,826 Cr, +28.7% on the year before.

Recent pace: the last four quarters grew +17.6% on average, against 25.9% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +16.4%, against +42.2% a year over the last 8 quarters (rolling over); profit over the last 12 months grew −18.1%, against +47.6% a year (rolling over).

Paradeep Phosphates Ltd's operating margin was 6.0% in the Sep 2026 quarter, 4.0 percentage points lower than the same quarter a year ago. Across 8 years it has been between 6.0% and 11.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −4.0 percentage points on the year while gross margin changed −4.6 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 118% of Paradeep Phosphates Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 its operations used ₹1,012 Cr of cash, against ₹996 Cr of profit. After ₹1,075 Cr of spending on assets, free cash was −₹2,087 Cr: it spent more than its operations brought in.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 118% of profit came in as cash: the cash cycle got 37 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives.

What to look at next: the bigger use of cash is spending on new assets, at 4.0× depreciation over three years. The next section checks what that spending is building.

Paradeep Phosphates Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 115 days in FY26, up from 78 days in FY21. It spent ₹3,839 Cr on assets over the last 3 years. Customers take 80 days to pay, and stock sits for 105 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹21,826 Cr, each day of that cycle ties up about ₹59.8 Cr, so roughly ₹6,877 Cr is tied up in the business at any time.

FY26: customers took 80 days to pay and stock sat for 105 days, about 3.5 months of sales sitting as stock, for a full cycle of 115 days, longer than FY21's 78.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 105 days. Customers pay about 80 days after that. Suppliers are paid at 70 days. Together that makes the 115-day cycle.

Spending on assets: ₹3,839 Cr over the last 3 years, against ₹958 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹424 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Paradeep Phosphates Ltd's P/E is 16.5×, in the middle of its own history: higher than 46% of past readings. Its usual P/E (the middle reading) is 16.9×, over 4.4 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Sep 2026 add up to ₹8.20.

Why the multiple is where it is: over the past year earnings per share moved +18.2% while the price moved −21.1%. Earnings did better than the price, which pulled the multiple down within its own range.

Where the price move came from: over 3 years the price moved +28.9% a year; about +77.5% a year came from earnings growth and about −48.6 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple.

The PEG ratio and its quarterly curve, which only the second data source has, are not shown on this page: its two data sources disagree by up to 58% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data.

Paradeep Phosphates Ltd's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE rising at 15.0%; each line tells part of the story. This is based on 9 quarters of 4 measures, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: when the lines disagree, each line above matters more than any single label.

The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone.

This reading has some gaps: at least one line is short, or the return line is not the quarterly series, so treat it with a little more caution.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Paradeep Phosphates Ltd earned a ROCE of 15% in FY26. That is up from a low of 7% in FY24. We cannot compare its return on capital used with its cost of capital from the data we have. It comes from a 4.6% net margin and 1.22× asset turnover (sales divided by assets).

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Why the return is what it is (FY26): a 4.6% net margin × 1.22× asset turnover × 2.64× leverage (assets divided by equity) ≈ 14.8% on equity. The margin does its share; borrowing is a big part of it.

The quarterly return lines and the return-on-capital-used (ROIC) line, which only the second data source has, are not shown on this page: its two data sources disagree by up to 58% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data.

Paradeep Phosphates Ltd had ₹6,906 Cr of borrowings against ₹6,783 Cr of equity in FY26, so its debt is 1.02× its equity. Its operating profit is 4 times its interest bill. Over 5 years borrowings went from ₹1,251 Cr to ₹6,906 Cr. Over the last 3 of those years it spent ₹3,839 Cr on assets.

Debt-to-equity shows how much of the business is paid for with borrowed money. Interest cover shows how many times operating profit pays the interest bill. Low debt and high cover are the safe combination.

Part of the spending on assets is being paid for with borrowed money.

The total-debt and debt-to-equity series, which only the second data source has, are not shown on this page: its two data sources disagree by up to 58% on reported income across 15 comparable periods. When two sources disagree on a figure, we leave it out on purpose. The gap is a choice, not missing data.

Domestic institutions cut their stake in Paradeep Phosphates Ltd by 6.8 percentage points over 8 quarters, the biggest change among its owners. Domestic institutions now own 20.3% of the company. Foreign institutions moved +2.7 points over the same period, to 4.8%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Domestic institutions: −6.8 points over 8 quarters, to 20.3%; Foreign institutions: +2.7 points over 8 quarters, to 4.8%; Promoters: +1.8 points over 8 quarters, to 57.9%.

Why the owners changed: foreign institutions moved +2.7 points and domestic institutions −6.8 points over 8 quarters, while promoters moved +1.8 points. One group of institutions took over shares from the other; it is not a change of mind by the people running the company.

For Paradeep Phosphates Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

44.5 out of 100, rank 11 of 15 in Fertilisers, with 67% of the evidence available.

Paradeep Phosphates Ltd scores 44.5 out of 100 against the 15 companies it is compared with in Fertilisers, ranking 11. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 11.9 + 10.9 + 11.2 + 10.5 = 44.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Paradeep Phosphates ranks 11 of 15 Fertilisers companies on the 4-Factor Sector Score, with 44.5 out of 100.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Fertilisers, all 15 compared on one page.

Paradeep Phosphates is the 5th largest of 15 Fertilisers companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Fertilizers & Chemicals Travancore, Deepak Fertilisers & Petrochemicals Corp and Chambal Fertilisers & Chemicals. Just below it: Madhya Bharat Agro Products, Gujarat Narmada Valley Fertilizers & Chemicals and Krishana Phoschem.

Fertilisers companies close in size

2. Fertilizers & Chemicals Travancore Ltd ₹43,360 crore
3. Deepak Fertilisers & Petrochemicals Corp Ltd ₹14,738 crore
4. Chambal Fertilisers & Chemicals Ltd ₹14,179 crore
5. Paradeep Phosphates Ltd ₹13,407 crore
6. Madhya Bharat Agro Products Ltd ₹8,127 crore
7. Gujarat Narmada Valley Fertilizers & Chemicals Ltd ₹7,415 crore
8. Krishana Phoschem Ltd ₹7,065 crore

All 15 Fertilisers companies, largest first

Companies close in size in other industries

487. JSW Dulux Ltd ₹13,436 crore · Building Materials - Paints
488. Niva Bupa Health Insurance Company Ltd ₹13,435 crore · Finance - Insurance
489. Paradeep Phosphates Ltd ₹13,407 crore
490. CIE Automotive India Ltd ₹13,384 crore · Castings, Forgings & Fastners
491. Arvind Ltd ₹13,346 crore · Textiles

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.